Authors


Whitney J. Palmer

Latest:

Diabetes, Hypertension Linked to COVID-19-Related Neurological Complications

About 20% of 81 positive patients experienced critical neurological complications; further, half had a pre-existing history of high blood pressure or type 2 diabetes.



Deepak Bhatt, MD, MPH

Latest:

Concluding Thoughts

A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.



Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center

Latest:

Schizophrenia: Practice, Patients, and Treatment

A panel of experts in schizophrenic psychiatric care share their thoughts on the practice, patients, and treatment based on their years of experience.


Korey Capozza, MPH

Latest:

Unmet Needs in Managing Atopic Dermatitis

Elizabeth A. Swanson, MD, and Raj. J. Chovatiya, MD, PhD, examine challenges in managing atopic dermatitis and explore the evolving treatment landscape.



Amy Pollak, MD

Latest:

Concluding Thoughts

A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.


Brett King, MD

Latest:

Use of JAK Inhibitors in Granuloma Annulare, Sarcoidosis, and Lichen Planus

Experts in dermatology review how JAK inhibitors will impact dermatology care across the board.


Kim Zuber, DNP

Latest:

Making Sense of Hepatitis C Management in Chronic Kidney Disease

Kim Zuber, PA-C, and Jane Davis, DNP, provide perspective on guideline recommendations for the management of hepatitis C in people with chronic kidney disease from the Kidney Disease Improving Global Outcomes.


Ravi Shah, MD

Latest:

Upadacitinib: An Evolving Treatment for Ulcerative Colitis

The inhibition of Janus kinase to prevent downstream signaling of proinflammatory cytokines has been shown to be a novel method of treating ulcerative colitis.


Dareen Siri, MD, FAAAAI, FACAAI

Latest:

Final Thoughts on Management of Nasal Polyposis

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri share takeaway thoughts on the management of nasal polyposis.


Henry Nasrallah, MD, University of Cincinnati College of Medicine

Latest:

Schizophrenia: Practice, Patients, and Treatment

A panel of experts in schizophrenic psychiatric care share their thoughts on the practice, patients, and treatment based on their years of experience.


Mithu Maheswaranathan, MD

Latest:

Is PJP Prophylaxis Indicated in Patients With Giant Cell Arteritis or Polymyalgia Rheumatica?

Results of a recent study showed that the risk of pneumocystis jiroveci pneumonia (PJP) is low in patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR), therefore discouraging the routine prescribing of PJP prophylaxis for this patient population.


Yi Qin, MD

Latest:

A Deep Dive Into the 2022 ACG GERD Guideline Update

A review of changes to clinical, dietary and screening strategies for patients with GERD.


Nirmish Ramesh Shah, MD, Duke University

Latest:

Sickle Cell Disease: Unmet Needs and Future Directions in Care

Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.


Patricia Ares-Romero, MD, FASAM

Latest:

Optimizing the Management of TRD

An expert panel shares insight on the future treatment landscape for treatment-resistant depression.


Diana Do, MD, Stanford University School of Medicine

Latest:

Innovative Therapies on the Horizon to Treat AMD

Carl Regillo, MD and Diana Do, MD react to newer therapies being explored for wet AMD and discuss their place in future therapeutic algorithms.


Alexa Hetzel, MS, PA-C

Latest:

Clinical Pearls and Educational Needs in Plaque Psoriasis

Experts in dermatology share practice pearls to advanced practice providers and community dermatologists for the management of plaque psoriasis.


Connor Iapoce

Latest:

High Fitness Levels May Lessen CVD Mortality Risk in Men With Hypertension

High blood pressure and low fitness levels were each associated with an increased risk of CVD mortality independently of established and emerging risk factors in new findings.



Heather Woolery-Lloyd, MD

Latest:

The Vitiligo Patient Journey

In this program, we will engage in discussions with a vitiligo patient to explore the impact of the condition on their daily lives, the challenges they face with treatment, and how they manage expectations related to living with vitiligo.


George Han, MD, PhD

Latest:

Challenges and Advantages in Use and Access to Biologics for Atopic Dermatitis

Drs Raj Chovatiya, George Han, and Vivian Shi review the current challenges and opportunities surrounding the utilization and availability of biologic therapies in atopic dermatitis.


Regino P. Gonzalez-Peralta, MD

Latest:

Clinical Pearls for the Management of ALGS

Experts in pediatric hepatology share advice for the optimal management of Alagille syndrome.



Jessica Allegretti, MD, MPH

Latest:

Emerging Treatments Over the Horizon for IBD

Jessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.


Carrie Jardine

Latest:

Optimizing the Management of TRD

An expert panel shares insight on the future treatment landscape for treatment-resistant depression.


Carl Regillo, MD, Thomas Jefferson University School of Medicine

Latest:

Innovative Therapies on the Horizon to Treat AMD

Carl Regillo, MD and Diana Do, MD react to newer therapies being explored for wet AMD and discuss their place in future therapeutic algorithms.


Paul Feuerstadt, MD

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


Adam Friedman, MD, FAAD, The George Washington School of Medicine & Health Sciences

Latest:

COVID-19 and Payor Strategies for Non-Medical Switching

Adam Friedman, MD, FAAD discusses how payors accelerated non-medical switching during COVID-19 and how healthcare providers can respond to new challenges. 

© 2023 MJH Life Sciences

All rights reserved.